Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy and safety of pemetrexed monotherapy as
salvage treatment in patients with relapsed or metastatic squamous cell carcinoma of head and
neck.